Skin Hypersensitivity to Oral Budesonide: Case Report and Review of the FDA Adverse Event Reporting System Database

Abstract

Get full access to this article

View all access options for this article.

References

Bezzio

Festa

Zerboni

Papi

Manes

Saibeni

A safety evaluation of budesonide MMX for the treatment of ulcerative colitis. Expert Opin Drug Saf. 2018;17:437-444. doi:10.1080/14740338.2018.1442432

Danielsson

Prytz

Oral budesonide for treatment of autoimmune chronic active hepatitis. Aliment Pharmacol Ther. 1994;8:585-590.

Peiseler

Liebscher

Sebode

et al . Efficacy and limitations of budesonide as a second-line treatment for patients with autoimmune hepatitis. Clin Gastroenterol Hepatol. 2018;16:260-267.e1. doi:10.1016/j.cgh.2016.12.040

Naranjo

Busto

Sellers

et al . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.

Vatti

Ali

Teuber

Chang

Gershwin

ME.

Hypersensitivity reactions to corticosteroids. Clin Rev Allergy Immunol. 2014;47:26-37. doi:10.1007/s12016-013-8365-z